Mario Santiago
Concepts (399)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Friend murine leukemia virus | 17 | 2021 | 29 | 6.030 |
Why?
| | Retroviridae Infections | 21 | 2024 | 46 | 5.470 |
Why?
| | Cytidine Deaminase | 21 | 2024 | 61 | 5.280 |
Why?
| | HIV-1 | 30 | 2024 | 857 | 3.240 |
Why?
| | Virus Replication | 19 | 2024 | 479 | 2.470 |
Why?
| | Antibodies, Neutralizing | 10 | 2022 | 282 | 2.400 |
Why?
| | Simian Immunodeficiency Virus | 19 | 2015 | 87 | 1.890 |
Why?
| | HIV Infections | 22 | 2024 | 2812 | 1.880 |
Why?
| | Interferon-alpha | 7 | 2020 | 198 | 1.870 |
Why?
| | Antiviral Agents | 9 | 2022 | 736 | 1.850 |
Why?
| | Antibodies, Viral | 12 | 2022 | 622 | 1.730 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 3 | 2022 | 19 | 1.700 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 11 | 2015 | 85 | 1.570 |
Why?
| | Antigens, CD | 5 | 2016 | 522 | 1.490 |
Why?
| | Tumor Virus Infections | 8 | 2024 | 47 | 1.460 |
Why?
| | Dendritic Cells | 5 | 2020 | 484 | 1.370 |
Why?
| | Gastrointestinal Tract | 3 | 2022 | 193 | 1.330 |
Why?
| | Adaptive Immunity | 3 | 2021 | 164 | 1.200 |
Why?
| | Immunity, Innate | 12 | 2024 | 826 | 1.170 |
Why?
| | Interferon Type I | 7 | 2022 | 141 | 1.090 |
Why?
| | Membrane Glycoproteins | 3 | 2016 | 500 | 1.080 |
Why?
| | CD4-Positive T-Lymphocytes | 11 | 2022 | 1092 | 0.940 |
Why?
| | Interferons | 3 | 2024 | 199 | 0.920 |
Why?
| | Pan troglodytes | 11 | 2009 | 61 | 0.900 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 2 | 2021 | 11 | 0.890 |
Why?
| | Mice, Inbred BALB C | 11 | 2024 | 1267 | 0.790 |
Why?
| | Immunoglobulin A | 2 | 2022 | 210 | 0.740 |
Why?
| | Animals | 63 | 2025 | 36768 | 0.720 |
Why?
| | Mice, Knockout | 13 | 2024 | 2999 | 0.710 |
Why?
| | Interferon-beta | 2 | 2020 | 92 | 0.710 |
Why?
| | Viral Load | 9 | 2021 | 460 | 0.670 |
Why?
| | B-Lymphocytes | 6 | 2023 | 846 | 0.660 |
Why?
| | Virion | 4 | 2016 | 90 | 0.640 |
Why?
| | Mice | 28 | 2025 | 17731 | 0.610 |
Why?
| | Proteins | 6 | 2022 | 1009 | 0.610 |
Why?
| | CD8-Positive T-Lymphocytes | 8 | 2021 | 913 | 0.600 |
Why?
| | Leukemia, Experimental | 4 | 2014 | 27 | 0.590 |
Why?
| | Killer Cells, Natural | 5 | 2016 | 445 | 0.590 |
Why?
| | Endogenous Retroviruses | 2 | 2024 | 36 | 0.580 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 885 | 0.570 |
Why?
| | Mice, Inbred C57BL | 17 | 2025 | 5744 | 0.570 |
Why?
| | RNA, Viral | 9 | 2024 | 651 | 0.540 |
Why?
| | Enterobacteriaceae | 1 | 2017 | 40 | 0.530 |
Why?
| | Host-Pathogen Interactions | 5 | 2024 | 364 | 0.530 |
Why?
| | Receptor, Interferon alpha-beta | 3 | 2024 | 34 | 0.530 |
Why?
| | Immunity, Cellular | 2 | 2016 | 268 | 0.490 |
Why?
| | Immunoglobulin Variable Region | 1 | 2015 | 80 | 0.470 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 83 | 0.470 |
Why?
| | Immunomodulation | 1 | 2016 | 97 | 0.460 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 40 | 0.450 |
Why?
| | Feces | 10 | 2017 | 479 | 0.440 |
Why?
| | Viremia | 6 | 2020 | 138 | 0.440 |
Why?
| | Dysbiosis | 4 | 2022 | 180 | 0.440 |
Why?
| | Signal Transduction | 6 | 2024 | 5065 | 0.430 |
Why?
| | Intestines | 1 | 2017 | 359 | 0.420 |
Why?
| | Virus Diseases | 3 | 2022 | 214 | 0.400 |
Why?
| | Endoribonucleases | 1 | 2013 | 80 | 0.400 |
Why?
| | Antibody Formation | 3 | 2017 | 298 | 0.390 |
Why?
| | Colon | 5 | 2024 | 280 | 0.380 |
Why?
| | Molecular Sequence Data | 15 | 2014 | 2903 | 0.360 |
Why?
| | Antibody Affinity | 1 | 2010 | 60 | 0.330 |
Why?
| | HIV Seropositivity | 2 | 2022 | 125 | 0.330 |
Why?
| | Spleen | 5 | 2018 | 513 | 0.320 |
Why?
| | Retroviridae | 3 | 2023 | 99 | 0.320 |
Why?
| | Antigens, Helminth | 2 | 1999 | 12 | 0.320 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 973 | 0.320 |
Why?
| | Cercocebus atys | 3 | 2006 | 6 | 0.310 |
Why?
| | Intestinal Mucosa | 4 | 2019 | 620 | 0.310 |
Why?
| | HIV-2 | 3 | 2006 | 18 | 0.310 |
Why?
| | Schistosomiasis japonica | 2 | 1999 | 32 | 0.310 |
Why?
| | Humans | 60 | 2024 | 136783 | 0.300 |
Why?
| | Animals, Wild | 3 | 2005 | 58 | 0.300 |
Why?
| | Base Sequence | 7 | 2015 | 2180 | 0.300 |
Why?
| | Interleukin-15 | 2 | 2021 | 97 | 0.290 |
Why?
| | Macaca mulatta | 5 | 2021 | 167 | 0.290 |
Why?
| | Cells, Cultured | 10 | 2018 | 4194 | 0.290 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 2190 | 0.290 |
Why?
| | Lymphocyte Activation | 5 | 2017 | 1150 | 0.290 |
Why?
| | Antigen Presentation | 2 | 2021 | 215 | 0.280 |
Why?
| | Lymphocytes | 2 | 2021 | 395 | 0.280 |
Why?
| | Reverse Transcription | 2 | 2021 | 19 | 0.280 |
Why?
| | Ape Diseases | 3 | 2008 | 7 | 0.280 |
Why?
| | Immunity, Humoral | 2 | 2022 | 117 | 0.280 |
Why?
| | Disease Reservoirs | 2 | 2006 | 21 | 0.270 |
Why?
| | Gastrointestinal Microbiome | 5 | 2024 | 696 | 0.270 |
Why?
| | Gene Expression Profiling | 6 | 2024 | 1768 | 0.270 |
Why?
| | Flow Cytometry | 4 | 2017 | 1181 | 0.260 |
Why?
| | Immunity, Mucosal | 3 | 2020 | 97 | 0.250 |
Why?
| | Papillomavirus Infections | 2 | 2022 | 324 | 0.250 |
Why?
| | Sequence Analysis, DNA | 5 | 2017 | 811 | 0.250 |
Why?
| | Genetic Variation | 4 | 2015 | 985 | 0.230 |
Why?
| | Thymocytes | 1 | 2025 | 35 | 0.230 |
Why?
| | Phylogeny | 13 | 2017 | 896 | 0.230 |
Why?
| | Immunoglobulin G | 4 | 2022 | 886 | 0.230 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2025 | 72 | 0.230 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 2024 | 44 | 0.230 |
Why?
| | Frameshifting, Ribosomal | 1 | 2024 | 6 | 0.230 |
Why?
| | HIV Long Terminal Repeat | 1 | 2024 | 11 | 0.230 |
Why?
| | Granzymes | 2 | 2022 | 49 | 0.220 |
Why?
| | Interferon-gamma | 2 | 2019 | 790 | 0.220 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2022 | 107 | 0.220 |
Why?
| | Bone Marrow Cells | 3 | 2016 | 316 | 0.220 |
Why?
| | Disease Models, Animal | 5 | 2018 | 4279 | 0.220 |
Why?
| | Cercopithecus | 1 | 2003 | 3 | 0.220 |
Why?
| | Immunoglobulin M | 4 | 2022 | 288 | 0.220 |
Why?
| | Alternative Splicing | 2 | 2024 | 227 | 0.220 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 122 | 0.210 |
Why?
| | DNA, Viral | 3 | 2021 | 362 | 0.210 |
Why?
| | Exons | 1 | 2024 | 349 | 0.210 |
Why?
| | Transcriptome | 2 | 2022 | 971 | 0.210 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2025 | 337 | 0.200 |
Why?
| | NF-kappa B | 2 | 2018 | 691 | 0.200 |
Why?
| | Antibodies, Helminth | 2 | 1999 | 6 | 0.200 |
Why?
| | Recombination, Genetic | 4 | 2015 | 198 | 0.190 |
Why?
| | Genome, Viral | 1 | 2003 | 144 | 0.190 |
Why?
| | Viral Regulatory and Accessory Proteins | 2 | 2016 | 28 | 0.180 |
Why?
| | HEK293 Cells | 5 | 2024 | 728 | 0.180 |
Why?
| | Blood | 1 | 2022 | 106 | 0.180 |
Why?
| | Ruminococcus | 1 | 2021 | 9 | 0.180 |
Why?
| | Acute Disease | 2 | 2016 | 1006 | 0.180 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2023 | 137 | 0.180 |
Why?
| | RNA, Messenger | 3 | 2024 | 2831 | 0.180 |
Why?
| | Acinetobacter | 1 | 2021 | 15 | 0.180 |
Why?
| | Peripheral Tolerance | 2 | 2020 | 15 | 0.180 |
Why?
| | Lymphopenia | 1 | 2021 | 61 | 0.180 |
Why?
| | Male | 22 | 2024 | 67361 | 0.170 |
Why?
| | Evolution, Molecular | 3 | 2016 | 488 | 0.170 |
Why?
| | Female | 24 | 2024 | 72840 | 0.170 |
Why?
| | Bacterial Translocation | 2 | 2019 | 43 | 0.170 |
Why?
| | Specimen Handling | 1 | 2022 | 178 | 0.170 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2020 | 19 | 0.170 |
Why?
| | Picornaviridae | 1 | 2020 | 18 | 0.170 |
Why?
| | Tropomyosin | 1 | 1999 | 14 | 0.160 |
Why?
| | Immunologic Factors | 2 | 2019 | 237 | 0.160 |
Why?
| | Salmonella typhimurium | 1 | 2021 | 182 | 0.160 |
Why?
| | Cell Line | 6 | 2020 | 2836 | 0.160 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 19 | 0.160 |
Why?
| | Keratinocytes | 2 | 2018 | 248 | 0.150 |
Why?
| | Genotype | 3 | 2013 | 1919 | 0.150 |
Why?
| | Sialic Acid Binding Ig-like Lectin 1 | 1 | 2018 | 4 | 0.150 |
Why?
| | Helminth Proteins | 1 | 1999 | 24 | 0.150 |
Why?
| | GPI-Linked Proteins | 2 | 2016 | 70 | 0.150 |
Why?
| | Gram-Positive Bacteria | 1 | 2019 | 49 | 0.150 |
Why?
| | Lymph Nodes | 3 | 2018 | 492 | 0.150 |
Why?
| | Interleukin-2 | 2 | 2022 | 454 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2021 | 369 | 0.150 |
Why?
| | Gram-Negative Bacteria | 1 | 2019 | 75 | 0.150 |
Why?
| | Lectins | 1 | 2018 | 49 | 0.150 |
Why?
| | Protective Agents | 1 | 2018 | 40 | 0.150 |
Why?
| | Sexually Transmitted Diseases, Viral | 1 | 1998 | 9 | 0.150 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.150 |
Why?
| | Cullin Proteins | 1 | 2018 | 12 | 0.150 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2018 | 172 | 0.140 |
Why?
| | HIV | 3 | 2018 | 233 | 0.140 |
Why?
| | Human papillomavirus 16 | 1 | 2018 | 35 | 0.140 |
Why?
| | Human Immunodeficiency Virus Proteins | 2 | 2016 | 6 | 0.140 |
Why?
| | APOBEC-1 Deaminase | 2 | 2014 | 5 | 0.140 |
Why?
| | Viral Tropism | 1 | 2017 | 30 | 0.140 |
Why?
| | Proteome | 1 | 2022 | 472 | 0.140 |
Why?
| | Interleukins | 1 | 2019 | 251 | 0.140 |
Why?
| | Proteolysis | 1 | 2018 | 178 | 0.140 |
Why?
| | Allergens | 1 | 2020 | 407 | 0.130 |
Why?
| | Immunoglobulin E | 1 | 1999 | 341 | 0.130 |
Why?
| | Parvoviridae Infections | 1 | 2016 | 12 | 0.130 |
Why?
| | Toll-Like Receptor 7 | 1 | 2016 | 39 | 0.130 |
Why?
| | Mutagenesis, Insertional | 1 | 2016 | 65 | 0.130 |
Why?
| | Disease Resistance | 1 | 2016 | 33 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 624 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 4 | 2024 | 556 | 0.130 |
Why?
| | Butyrates | 1 | 2017 | 61 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2022 | 3537 | 0.130 |
Why?
| | Interleukin-12 | 1 | 2016 | 121 | 0.130 |
Why?
| | Lymphoid Tissue | 2 | 2020 | 75 | 0.120 |
Why?
| | Amino Acid Sequence | 6 | 2016 | 2145 | 0.120 |
Why?
| | Biological Products | 1 | 2019 | 215 | 0.120 |
Why?
| | B7-1 Antigen | 1 | 2016 | 58 | 0.120 |
Why?
| | Primates | 2 | 2015 | 124 | 0.120 |
Why?
| | NIH 3T3 Cells | 1 | 2016 | 144 | 0.120 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 162 | 0.120 |
Why?
| | Gene Products, nef | 2 | 2006 | 12 | 0.120 |
Why?
| | Antibody Diversity | 1 | 2015 | 16 | 0.120 |
Why?
| | Phenotype | 2 | 2016 | 3199 | 0.120 |
Why?
| | Toll-Like Receptor 3 | 1 | 2014 | 28 | 0.120 |
Why?
| | Major Histocompatibility Complex | 1 | 2016 | 227 | 0.120 |
Why?
| | Colobus | 1 | 2014 | 3 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2019 | 2473 | 0.110 |
Why?
| | Histones | 1 | 2020 | 635 | 0.110 |
Why?
| | Endocytosis | 1 | 2016 | 168 | 0.110 |
Why?
| | Gene Expression Regulation | 4 | 2024 | 2603 | 0.110 |
Why?
| | Bacteria | 2 | 2022 | 855 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 387 | 0.110 |
Why?
| | Autoimmunity | 1 | 2020 | 908 | 0.110 |
Why?
| | Cote d'Ivoire | 2 | 2005 | 9 | 0.110 |
Why?
| | Neoplasms | 2 | 2022 | 2644 | 0.110 |
Why?
| | Cloning, Molecular | 3 | 2013 | 534 | 0.110 |
Why?
| | Biological Evolution | 2 | 2012 | 464 | 0.110 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 16 | 0.110 |
Why?
| | Germinal Center | 1 | 2014 | 58 | 0.110 |
Why?
| | Gene Frequency | 1 | 2015 | 520 | 0.110 |
Why?
| | Papillomaviridae | 1 | 2014 | 126 | 0.110 |
Why?
| | Prevalence | 4 | 2006 | 2712 | 0.110 |
Why?
| | APOBEC Deaminases | 2 | 2024 | 6 | 0.110 |
Why?
| | Immunization | 2 | 2020 | 410 | 0.110 |
Why?
| | Virus Integration | 1 | 2013 | 71 | 0.100 |
Why?
| | T-Lymphocyte Subsets | 1 | 2016 | 425 | 0.100 |
Why?
| | DNA Damage | 1 | 2015 | 418 | 0.100 |
Why?
| | Uganda | 2 | 2003 | 72 | 0.100 |
Why?
| | Amino Acids | 1 | 2016 | 500 | 0.100 |
Why?
| | Tanzania | 2 | 2003 | 58 | 0.100 |
Why?
| | Urine | 2 | 2003 | 55 | 0.100 |
Why?
| | Adult | 10 | 2024 | 37616 | 0.100 |
Why?
| | Inbreeding | 1 | 2012 | 18 | 0.100 |
Why?
| | Cell Membrane | 1 | 2016 | 736 | 0.090 |
Why?
| | Down-Regulation | 3 | 2018 | 657 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 33200 | 0.090 |
Why?
| | Neutralization Tests | 2 | 2008 | 75 | 0.090 |
Why?
| | Carcinogenesis | 2 | 2024 | 217 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 535 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2012 | 409 | 0.090 |
Why?
| | Philippines | 3 | 2001 | 51 | 0.090 |
Why?
| | Mutation | 3 | 2024 | 3953 | 0.090 |
Why?
| | DNA Primers | 3 | 2013 | 513 | 0.090 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2010 | 13 | 0.090 |
Why?
| | Protein Isoforms | 2 | 2024 | 400 | 0.090 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 3 | 0.090 |
Why?
| | Leukemia Virus, Murine | 1 | 2010 | 18 | 0.090 |
Why?
| | CD4 Antigens | 3 | 2006 | 141 | 0.090 |
Why?
| | Phenylacetates | 1 | 2010 | 9 | 0.090 |
Why?
| | Cytosine Deaminase | 1 | 2010 | 16 | 0.080 |
Why?
| | Gene Products, gag | 1 | 2010 | 36 | 0.080 |
Why?
| | Nitrophenols | 1 | 2010 | 34 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 849 | 0.080 |
Why?
| | Young Adult | 4 | 2020 | 13126 | 0.080 |
Why?
| | Plasma | 1 | 2011 | 213 | 0.080 |
Why?
| | Escherichia coli | 1 | 2014 | 812 | 0.080 |
Why?
| | Lentivirus | 2 | 2013 | 56 | 0.080 |
Why?
| | Retroelements | 2 | 2024 | 47 | 0.080 |
Why?
| | Apoptosis | 3 | 2014 | 2548 | 0.080 |
Why?
| | T-Lymphocytes | 3 | 2020 | 1998 | 0.080 |
Why?
| | Sequence Analysis, RNA | 1 | 2011 | 451 | 0.080 |
Why?
| | Molecular Epidemiology | 2 | 2006 | 67 | 0.080 |
Why?
| | Simian foamy virus | 1 | 2008 | 3 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2011 | 387 | 0.070 |
Why?
| | Receptors, Antigen, B-Cell | 2 | 2020 | 130 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 2008 | 523 | 0.070 |
Why?
| | Phosphorylation | 2 | 2025 | 1756 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2834 | 0.070 |
Why?
| | Immunotherapy | 2 | 2023 | 640 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1250 | 0.070 |
Why?
| | Lentiviruses, Primate | 1 | 2006 | 13 | 0.060 |
Why?
| | Cross-Sectional Studies | 4 | 2018 | 5417 | 0.060 |
Why?
| | Genes, env | 1 | 2005 | 5 | 0.060 |
Why?
| | Genes, gag | 1 | 2005 | 4 | 0.060 |
Why?
| | Blotting, Western | 3 | 2010 | 1225 | 0.060 |
Why?
| | Social Dominance | 1 | 2005 | 21 | 0.060 |
Why?
| | Disease Transmission, Infectious | 1 | 2005 | 61 | 0.060 |
Why?
| | V(D)J Recombination | 1 | 2025 | 8 | 0.060 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2024 | 17 | 0.060 |
Why?
| | RNA Transport | 1 | 2024 | 23 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.060 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2004 | 25 | 0.050 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2024 | 30 | 0.050 |
Why?
| | Dependovirus | 2 | 2016 | 68 | 0.050 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2005 | 182 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1117 | 0.050 |
Why?
| | Endemic Diseases | 1 | 2003 | 32 | 0.050 |
Why?
| | Time Factors | 1 | 2014 | 6792 | 0.050 |
Why?
| | Retroviridae Proteins | 1 | 2003 | 11 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2018 | 1354 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2162 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2006 | 382 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 232 | 0.050 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2022 | 22 | 0.050 |
Why?
| | Cytidine | 1 | 2022 | 8 | 0.050 |
Why?
| | Apolipoproteins | 1 | 2022 | 33 | 0.050 |
Why?
| | Polymerase Chain Reaction | 2 | 2002 | 1059 | 0.050 |
Why?
| | Wuchereria bancrofti | 1 | 2001 | 1 | 0.050 |
Why?
| | Filariasis | 1 | 2001 | 3 | 0.050 |
Why?
| | DNA, Helminth | 1 | 2001 | 19 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2022 | 119 | 0.050 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 867 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 122 | 0.050 |
Why?
| | Immunoblotting | 1 | 2002 | 307 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 134 | 0.040 |
Why?
| | Hemagglutination | 1 | 2020 | 8 | 0.040 |
Why?
| | Antibodies | 1 | 2022 | 412 | 0.040 |
Why?
| | Macrophages | 2 | 2018 | 1541 | 0.040 |
Why?
| | COS Cells | 1 | 2020 | 188 | 0.040 |
Why?
| | Immune Evasion | 1 | 2020 | 58 | 0.040 |
Why?
| | Snails | 1 | 1999 | 35 | 0.040 |
Why?
| | Gene Library | 1 | 1999 | 117 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 185 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 2 | 2016 | 663 | 0.040 |
Why?
| | Erythroblasts | 1 | 2018 | 19 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 2 | 2014 | 267 | 0.040 |
Why?
| | Nucleic Acid Heteroduplexes | 1 | 1998 | 8 | 0.040 |
Why?
| | Sex Work | 1 | 1998 | 22 | 0.040 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2018 | 5 | 0.040 |
Why?
| | Sendai virus | 1 | 2018 | 17 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1942 | 0.040 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2018 | 54 | 0.040 |
Why?
| | THP-1 Cells | 1 | 2018 | 22 | 0.040 |
Why?
| | Rabbits | 1 | 1999 | 789 | 0.040 |
Why?
| | Enzyme Stability | 1 | 2018 | 73 | 0.040 |
Why?
| | I-kappa B Kinase | 1 | 2018 | 55 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 145 | 0.040 |
Why?
| | Antigenic Variation | 1 | 1997 | 10 | 0.030 |
Why?
| | Disease Progression | 2 | 2016 | 2750 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 499 | 0.030 |
Why?
| | Antigens, Protozoan | 1 | 1997 | 24 | 0.030 |
Why?
| | Autoantigens | 1 | 2020 | 428 | 0.030 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 12 | 0.030 |
Why?
| | Anti-Retroviral Agents | 1 | 2019 | 232 | 0.030 |
Why?
| | Plasmodium falciparum | 1 | 1997 | 30 | 0.030 |
Why?
| | Malaria, Falciparum | 1 | 1997 | 27 | 0.030 |
Why?
| | Cross Reactions | 1 | 2017 | 133 | 0.030 |
Why?
| | Palatine Tonsil | 1 | 2017 | 48 | 0.030 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2017 | 60 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 111 | 0.030 |
Why?
| | Gene Silencing | 1 | 2018 | 193 | 0.030 |
Why?
| | Antigens, Surface | 1 | 1997 | 153 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2019 | 372 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 86 | 0.030 |
Why?
| | Protozoan Proteins | 1 | 1997 | 82 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 85 | 0.030 |
Why?
| | APOBEC-3G Deaminase | 1 | 2016 | 6 | 0.030 |
Why?
| | Models, Biological | 1 | 2004 | 1769 | 0.030 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2016 | 13 | 0.030 |
Why?
| | Peptides | 1 | 2022 | 980 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 99 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 225 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2016 | 183 | 0.030 |
Why?
| | DNA, Mitochondrial | 2 | 2008 | 200 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 336 | 0.030 |
Why?
| | Imidazoles | 1 | 2016 | 239 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2017 | 495 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2018 | 467 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2014 | 21 | 0.030 |
Why?
| | Receptors, CCR7 | 1 | 2014 | 32 | 0.030 |
Why?
| | Protein Transport | 1 | 2016 | 442 | 0.030 |
Why?
| | Cervix Uteri | 1 | 2014 | 49 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1126 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 549 | 0.030 |
Why?
| | Sexual Behavior | 1 | 1998 | 485 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2014 | 180 | 0.030 |
Why?
| | Viral Proteins | 1 | 2016 | 343 | 0.030 |
Why?
| | Vaccines | 1 | 1999 | 406 | 0.030 |
Why?
| | Caspase 1 | 1 | 2014 | 143 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 284 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1428 | 0.030 |
Why?
| | Genetic Engineering | 1 | 2013 | 92 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2014 | 125 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 345 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1089 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2088 | 0.020 |
Why?
| | HIV Reverse Transcriptase | 1 | 2010 | 31 | 0.020 |
Why?
| | Glycosylation | 1 | 2010 | 163 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 969 | 0.020 |
Why?
| | L-Selectin | 1 | 2009 | 26 | 0.020 |
Why?
| | HIV Core Protein p24 | 1 | 2009 | 31 | 0.020 |
Why?
| | Autoantibodies | 1 | 2017 | 1500 | 0.020 |
Why?
| | DNA Replication | 1 | 2010 | 238 | 0.020 |
Why?
| | Aged | 2 | 2017 | 23729 | 0.020 |
Why?
| | Microbiota | 1 | 2017 | 761 | 0.020 |
Why?
| | Africa, Central | 1 | 2008 | 6 | 0.020 |
Why?
| | Genetics, Microbial | 1 | 2008 | 10 | 0.020 |
Why?
| | HLA-DR Antigens | 1 | 2009 | 228 | 0.020 |
Why?
| | Child | 2 | 2017 | 21968 | 0.020 |
Why?
| | Infant, Newborn | 1 | 1999 | 6046 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 1999 | 7569 | 0.020 |
Why?
| | Gene Products, pol | 1 | 2007 | 6 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2007 | 73 | 0.020 |
Why?
| | Ecology | 1 | 2008 | 117 | 0.020 |
Why?
| | Adolescent | 2 | 2012 | 21463 | 0.020 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2006 | 9 | 0.020 |
Why?
| | Cameroon | 1 | 2006 | 9 | 0.020 |
Why?
| | HIV Antibodies | 1 | 2006 | 62 | 0.020 |
Why?
| | Prospective Studies | 1 | 1998 | 7583 | 0.020 |
Why?
| | Infant | 1 | 1999 | 9442 | 0.020 |
Why?
| | Child, Preschool | 1 | 1999 | 11069 | 0.010 |
Why?
| | p21-Activated Kinases | 1 | 2004 | 15 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2004 | 53 | 0.010 |
Why?
| | Haplotypes | 1 | 2006 | 490 | 0.010 |
Why?
| | Africa, Western | 1 | 2004 | 17 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 376 | 0.010 |
Why?
| | Protein Binding | 1 | 2010 | 2223 | 0.010 |
Why?
| | Risk Factors | 1 | 1998 | 10331 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 389 | 0.010 |
Why?
| | HeLa Cells | 1 | 2005 | 636 | 0.010 |
Why?
| | Ecosystem | 1 | 2008 | 590 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 945 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 368 | 0.010 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 15 | 0.010 |
Why?
| | Africa | 1 | 2001 | 108 | 0.010 |
Why?
| | Malaria Vaccines | 1 | 1997 | 8 | 0.010 |
Why?
| | DNA, Protozoan | 1 | 1997 | 31 | 0.010 |
Why?
| | Point Mutation | 1 | 1997 | 234 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2004 | 3272 | 0.010 |
Why?
| | Epitopes | 1 | 1997 | 480 | 0.010 |
Why?
|
|
Santiago's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|